MedKoo Cat#: 561629 | Name: Glycocholate sodium

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Glycocholate sodium is a conjugated bile salt and ionic biologic detergent. It is involved in the emulsification of fats.

Chemical Structure

Glycocholate sodium
Glycocholate sodium
CAS#863-57-0

Theoretical Analysis

MedKoo Cat#: 561629

Name: Glycocholate sodium

CAS#: 863-57-0

Chemical Formula: C26H42NNaO6

Exact Mass:

Molecular Weight: 487.61

Elemental Analysis: C, 64.04; H, 8.68; N, 2.87; Na, 4.71; O, 19.69

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Glycocholate sodium; Glycocholic acid sodium salt;
IUPAC/Chemical Name
Sodium 2-[[(4R)-4-[(3R,7R,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetate
InChi Key
OABYVIYXWMZFFJ-BSWKNYTGSA-M
InChi Code
InChI=1S/C26H43NO6.Na/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29;/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33);/q;+1/p-1/t14-,15?,16-,17-,18?,19?,20-,21+,24?,25+,26-;/m1./s1
SMILES Code
O=C([O-])CNC(CC[C@H]([C@H]1CCC2C3[C@H](O)CC4C[C@H](O)CC[C@]4(C)C3C[C@H](O)[C@]12C)C)=O.[Na+]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 487.61 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Fuchs A, Leigh M, Kloefer B, Dressman JB. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3. Eur J Pharm Biopharm. 2015 Aug;94:229-40. doi: 10.1016/j.ejpb.2015.05.015. Epub 2015 May 29. Review. PubMed PMID: 26032292. 2: Zhou H, Hylemon PB. Bile acids are nutrient signaling hormones. Steroids. 2014 Aug;86:62-8. doi: 10.1016/j.steroids.2014.04.016. Epub 2014 May 10. Review. PubMed PMID: 24819989; PubMed Central PMCID: PMC4073476. 3: Woolbright BL, Jaeschke H. Novel insight into mechanisms of cholestatic liver injury. World J Gastroenterol. 2012 Sep 28;18(36):4985-93. doi: 10.3748/wjg.v18.i36.4985. Review. PubMed PMID: 23049206; PubMed Central PMCID: PMC3460324. 4: Rana SV, Bhardwaj SB. Small intestinal bacterial overgrowth. Scand J Gastroenterol. 2008;43(9):1030-7. doi: 10.1080/00365520801947074. Review. PubMed PMID: 18609165. 5: Robinson DM, Keating GM. Colesevelam: a review of its use in hypercholesterolemia. Am J Cardiovasc Drugs. 2007;7(6):453-65. Review. PubMed PMID: 18076213. 6: Yoneda M, Shimada T, Hiraishi H. [Cholyl glycine (CG)]. Nihon Rinsho. 2005 Aug;63 Suppl 8:806-8. Review. Japanese. PubMed PMID: 16149646. 7: Steinmetz KL. Colesevelam hydrochloride. Am J Health Syst Pharm. 2002 May 15;59(10):932-9. Review. PubMed PMID: 12040732. 8: Yoneda M, Terano A. [Cholylglycine (CG)]. Nihon Rinsho. 1999 Dec;57 Suppl:779-82. Review. Japanese. PubMed PMID: 10778239. 9: Marttin E, Verhoef JC, Merkus FW. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs. J Drug Target. 1998;6(1):17-36. Review. PubMed PMID: 9769018. 10: Holt PR. Clinical significance of bacterial overgrowth in elderly people. Age Ageing. 1992 Jan;21(1):1-4. Review. PubMed PMID: 1553853. 11: Fiasse R. [Bile salts. Physiology of the enterohepatic circulation, its disorders and functional studies]. Acta Gastroenterol Belg. 1988 Nov-Dec;51(6):491-500. Review. French. PubMed PMID: 3078472. 12: Almuna R, Galindo E, Sepúlveda V. [Bile salts (cholylglycine) in the amniotic fluid and umbilical cord blood in patients with intrahepatic cholestasis of pregnancy]. Rev Chil Obstet Ginecol. 1987;52(6):327-32. Review. Spanish. PubMed PMID: 3079209. 13: Rabinowitz JL, Lopez-Majano V. 14CO2 in breath. Eur J Nucl Med. 1981;6(5):213-9. Review. PubMed PMID: 6788552. 14: Aach RD, Kahn RA. Post-transfusion hepatitis: current perspectives. Ann Intern Med. 1980 Apr;92(4):539-46. Review. PubMed PMID: 6987932. 15: Barr RG, Perman JA, Schoeller DA, Watkins JB. Breath tests in pediatric gastrointestinal disorders: new diagnostic opportunities. Pediatrics. 1978 Sep;62(3):393-401. Review. PubMed PMID: 360155. 16: Dietary fiber as a binder of bile salts. Nutr Rev. 1977 Jul;35(7):183-5. Review. PubMed PMID: 331148. 17: Bile acid tolerance test and its use in hepatic disease. Nutr Rev. 1976 May;34(5):133-5. Review. PubMed PMID: 772488. 18: Bile acid excretion--a new test of functioning liver mass. Nutr Rev. 1975 Sep;33(9):285. Review. PubMed PMID: 1099487.